Chiesi’s Trimbow recommended for use within NHS Scotland
The SMC approval brings much-needed boost to asthma sufferers across Scotland
Read More
Tag: Trimbow
EU approves Chiesi’s triple combination asthma therapy Trimbow
European Commission has authorised treatment for uncontrolled asthma patients
Read More
EU nod for Chiesi’s COPD therapy
European regulators have green-lighted Chiesi’s new chronic obstructive pulmonary disease (COPD) maintenance therapy Trimbow.
Read More
Eleven therapies put forward for EU approval
Eleven new medicines have been put forward for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including new options for a rare eye disease, schizophrenia and cartilage defects.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
